MEBUATE – Gefitinib Tablet IP 250mg
Gefitinib Tablets IP 250 mg – Mebuate 250 mg Tablets
Composition:Gefitinib Tablets IP 250 mg
Dosage Form: Tablets
Packing: 30 Tablets
Market Authorization: MBA Pharmaceuticals Pvt Ltd
Country of Origin: India
Similar to IRESSA
Gefitinib is indicated as monotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies. The effectiveness of Gefitinib is based on objective response rates. There are non-controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival.
Dr. Prachi –
MBA all product are also good.